Moat Ross Insider Trading -- Recent SEC Form 4 Transactions
Moat Ross (CIK 1857177) reported 41 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-03). Recent activity: Buy KNSA (10,895 shares), Buy KNSA (21,059 shares), Buy KNSA (3,760 shares), Buy KNSA (1,658 shares), Buy KNSA (16,112 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 10,895 | $196,764 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 21,059 | $233,755 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 3,760 | $45,007 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 1,658 | $21,504 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 16,112 | $286,149 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 16,111 | $173,354 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 37,775 | $3.5M |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 722 | $67,904 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 8,430 | $792,167 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 6,282 | $596,287 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 3,672 | $352,622 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 1,760 | $170,896 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 2,575 | $251,732 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 9,412 | $169,981 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 12,302 | $267,815 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 6,263 | $143,360 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 6,681 | $609,508 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 8,932 | $822,191 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 11,642 | $1.1M |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 15,114 | $1.4M |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 2,477 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 1,611 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 1,740 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 2,457 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 4,007 | $317,675 |
Source: SEC Form 4 filings · as of 2026-11-03